GlassScriptPhysician profile
Alon Seifan
NPI 1083888432
$711.13
in general payments reported to CMS, 2019-2025
11 companies · none reported in 2025
See the full distribution for Neurology (Psychiatry & Neurology)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $443 · 2020: $190 · 2024: $78.25.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $78.25.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $78.25 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Allergan, INC. | $238.21 | 2019-2020 | |
| Lundbeck LLC | $152.00 | 2019 | |
| Axsome Therapeutics, INC. | $64.00 | 2024 | Auvelity |
| Takeda Pharmaceuticals U.S.A., INC. | $56.09 | 2019 | |
| Sunovion Pharmaceuticals INC. | $52.33 | 2019 | |
| Otsuka America Pharmaceutical, INC. | $39.56 | 2019 | |
| Collegium Pharmaceutical, INC. | $31.48 | 2019 | |
| Avanir Pharmaceuticals, INC. | $24.43 | 2019 | |
| Novartis Pharmaceuticals Corporation | $19.62 | 2020 | |
| Novo Nordisk INC | $19.16 | 2019 | |
| Pfizer INC. | $14.25 | 2024 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Alon Seifan listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.